SSA
SPPI

Schonfeld Strategic Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Schonfeld Strategic Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-14,800
Closed -$249K – 1274
2018
Q3 		$249K Sell
14,800
-4,200
-22% -$90.9K 0.01% 724
2018
Q2 		$399K Sell
19,000
-16,461
-46% -$305K 0.02% 578
2018
Q1 		$571K Buy
35,461
+12,757
+56% +$253K 0.04% 442
2017
Q4 		$430K Buy
+22,704
New +$411K 0.04% 497

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Schonfeld Strategic Advisors's SPPI Position: Q4 2018 in Review

Schonfeld Strategic Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2018, closing a stake of 14,800 shares — an estimated $249K sold.

Schonfeld Strategic Advisors first reported a position in SPPI in Q4 2017 and held it in 4 quarters. The position peaked at $571K in Q1 2018. 176 funds tracked by Wall St. Rank hold SPPI as of Q4 2018.

  • Schonfeld Strategic Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 14,800 Spectrum Pharmaceuticals Inc shares in Q4 2018, an estimated $249K.
  • Schonfeld Strategic Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q4 2017 and held it in 4 quarters.
  • Schonfeld Strategic Advisors's Spectrum Pharmaceuticals Inc position peaked at $571K in Q1 2018.
  • 176 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2018.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.